Association of peroxisome proliferator activated receptor-γ gene with non-alcoholic fatty liver disease in Asian Indians residing in north India

Gene

Volumn 512, Issue 1, 2013, Pages 143-147

  Bhatt, Surya Prakash ^a,c,d   Nigam, Priyanka ^b,d   Misra, Anoop ^b,d   Guleria, Randeep ^a   Luthra, Kalpana ^a   Pandey, Ravindra Mohan ^a   Pasha, M A Qadar ^c  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b Diabetes Foundation India New Delhi   (India)

^c CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^d Fortis C DOC Centre of Excellence for Diabetes Metabolic Diseases and Endocrinology   (India)

Author keywords

Asian Indians; Haplotype; Non alcoholic fatty liver disease; Peroxisome proliferator activated receptor

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ALLELE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ECHOGRAPHY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; GLUCOSE BLOOD LEVEL; HAPLOTYPE; HUMAN; INDIA; INDIAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FATTY LIVER; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA; RISK FACTORS;

EID: 84868618394     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.09.067     Document Type: Article

References (26)

1. Bajaj S Nigam P., Luthra A., et al. A case-control study on insulin resistance, metabolic co-variates & prediction score in non-alcoholic fatty liver disease. Indian J. Med. Res. 2009, 129:285-292.
2. Bhatt S.P., Misra A., Sharma M., Luthra K., et al. Ala/Ala Genotype of Pro12Ala Polymorphism in the Peroxisome Proliferator-Activated Receptor-γ2 Gene Is Associated with Obesity and Insulin Resistance in Asian Indians. Diabetes Technol. Ther. 2012, 14(9):828-834.
3. Brunt E.M., Janney C.G., et al. Non-alcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 1999, 94:2467-2474.
4. Cao C.Y., Li Y.Y., Zhou Y.J., et al. The C-681G polymorphism of the PPAR-γ gene is associated with susceptibility to non-alcoholic fatty liver disease. Tohoku J. Exp. Med. 2012, 227(4):253-262.
5. Deeb S.S., Fajas L., Nemoto M., et al. A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat. Genet. 1998, 20(3):284-287.
6. Desvergne B., Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 1999, 20:649-688.
7. Dongiovanni Raffaela R., Anna L., et al. Lack of association between PPARs alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study. BMC Gastroenterol. 2010, 10:102.
8. Gawrieh S., Marion M.C., Komorowski R., et al. Genetic variation in the peroxisome proliferator activated receptor-gamma gene is associated with histologically advanced NAFLD. Dig. Dis. Sci. 2012, 57(4):952-957.
9. Gupta A.C., Misra R., et al. Association of adiponectin gene functional polymorphisms (-11377C/G and +45T/G) with nonalcoholic fatty liver disease. Gene 2012, 496(1):63-67.
10. He W., Barak Y., Hevener A., et al. Adipose-specific PPAR gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc. Natl. Acad. Sci. U. S. A. 2003, 100(26):15712-15717.
11. Hui Y., Yu-Yuan L., Yu-Qiang N., et al. Effect of peroxisome proliferator-activated receptors-gamma and co-activator-1alpha genetic polymorphisms on plasma adiponectin levels and susceptibility of non-alcoholic fatty liver disease in Chinese people. Liver Int. 2008, 28(3):385-392.
12. Kotronen A., Yki-Järvinen H., et al. Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts. Eur. J. Endocrinol. 2009, 160(4):593-602.
13. Lahiri D.K., Nurmberger J.R. A rapid non- enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acid Res. 1991, 19(19):5444. 11.
14. Lambert M., Paradis G., Loughlin J., et al. Insulin resistance syndrome in a representative sample of children and adolescents from Qubec Canada. Int. J. Obes. Relat. Metab. Disord. 2004, 28:833-841.
15. Matthews D.R., Hosker J.P., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
16. Meirhaeghe A., Fajas L., Helbecque N., et al. A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans. Hum. Mol. Genet. 1998, 7:435-440.
17. Misra A., Khurana L. Obesity and the metabolic syndrome in developing countries. J. Clin. Endocrinol. Metab. 2008, 93(11 Suppl. 1):S9-S30.
18. Misra A., Chowbey P., Makkar B.M., et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J. Assoc. Physicians India 2009, 57:163-170.
19. Mohanty S.R., Troy T.N., Huo D., et al. Influence of ethnicity on histological differences in non-alcoholic fatty liver disease. J. Hepatol. 2009, 50(4):797-804.
20. Petersen K.F., Dufour S., Hariri A., et al. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N. Engl. J. Med. 2010, 36(12):1082-1089.
21. Raji A., Seely E.W., Arky R.A., et al. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J. Clin. Endocrinol. Metab. 2001, 86:5366-5371.
22. Rey J.W., Noetel A., Hardt A., Canbay A., et al. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 in patients with fatty liver diseases. World J. Gastroenterol. 2010, 16(46):5830-5837.
23. Shneider B.L., Gonzalez P.R., et al. Controversies in the management of pediatric liver disease: hepatitis B, C and NAFLD: summary of a single topic conference. Hepatology 2006, 44:1344-1354.
24. Tsochatzis E.A., Manolakopoulos S., Papatheodoridis G.V., et al. Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications. Scand. J. Gastroenterol. 2009, 44(1):6-14.
25. Vikram N.K., Misra A., Pandey R.M., et al. Association between subclinical inflammation & fasting insulin in urban young adult North Indian males. Indian J. Med. Res. 2006, 124:677-682.
26. Yang Z., Wen J., Li Q., et al. PPARG gene Pro12Ala variant contributes to the development of non-lcoholic fatty liver in middle-aged and older Chinese population. Mol. Cell. Endocrinol. 2012, 348(1):255-259.